Mirae Asset Global ETFs Holdings
BCAX

Mirae Asset Global ETFs Holdings’s Bicara Therapeutics BCAX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$708K Buy
23,892
+6,226
+35% +$139K ﹤0.01% 1810
2026
Q1 		$349K Sell
17,666
-474
-3% -$8.16K ﹤0.01% 2070
2025
Q4 		$303K Buy
18,140
+2,030
+13% +$34.7K ﹤0.01% 2151
2025
Q3 		$254K Sell
16,110
-2,619
-14% -$29.3K ﹤0.01% 2199
2025
Q2 		$174K Buy
18,729
+7,354
+65% +$87.6K ﹤0.01% 2354
2025
Q1 		$148K Buy
11,375
+468
+4% +$6.21K ﹤0.01% 2465
2024
Q4 		$190K Buy
+10,907
New +$227K ﹤0.01% 2407

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mirae Asset Global ETFs Holdings's BCAX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Bicara Therapeutics (BCAX) stake by 35% in Q2 2026, buying an estimated $139K and bringing the position to 23,892 shares worth $708K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Mirae Asset Global ETFs Holdings first reported a position in BCAX in Q4 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 23,892 shares of Bicara Therapeutics worth $708K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 6,226 Bicara Therapeutics shares in Q2 2026, an estimated $139K.
  • Bicara Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1810 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.